Flu

Vaccines will arrive gradually at clinics over the coming weeks. Health funds are calling on the public, especially high-risk populations, to get vaccinated as soon as the vaccines arrive. Last year, six children died from the virus.

The US Food and Drug Administration (FDA) has approved Moderna's Mfalusiva, the first seasonal flu vaccine based on mRNA technology. In a large-scale trial, the vaccine showed a 26.6% higher relative efficacy compared to a standard-dose flu vaccine.